selected publications
-
Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures.
STAR protocols.
2023
Academic Article
GET IT
Times cited: 25 -
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer.
Cancer cell.
2022
Academic Article
GET IT
Times cited: 3 -
The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62.
Cell reports.
2022
Academic Article
GET IT
Times cited: 12 -
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
Molecular cell.
2021
Academic Article
GET IT
Times cited: 7 -
POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation.
Oncogene.
2021
Academic Article
GET IT
Times cited: 19 -
Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.
Developmental cell.
2020
Academic Article
GET IT
Times cited: 27 -
HYPOTHesizing about central comBAT against obesity.
Journal of physiology and biochemistry.
2019
Review
GET IT
Times cited: 3 -
POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
The Journal of pathology.
2019
Academic Article
GET IT
Times cited: 19 -
Corneal regeneration by conditioned medium of human uterine cervical stem cells is mediated by TIMP-1 and TIMP-2.
Experimental eye research.
2018
Academic Article
GET IT
Times cited: 19 -
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Cellular oncology (Dordrecht).
2018
Academic Article
GET IT
Times cited: 64 -
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Oncogene.
2018
Academic Article
GET IT
Times cited: 45 -
Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor Activity.
Cancer genomics & proteomics.
2016
Review
GET IT
Times cited: 17 -
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.
Oncotarget.
2015
Academic Article
GET IT
Times cited: 11 - 26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines. Cancers. 2013 Academic Article GET IT